Cancer Dx Firm Cernostics Raises $1.4M

Cancer diagnostics and prognostics firm Cernostics recently announced it raised $1.4 million in a Series B financing round.... Read more

Cernostics raises $1.4M in Series B funding

A Pittsburgh-based life sciences company has raised $1.4 million in Series B funding for its work on a next-generation cancer diagnostic tool.... Read more

Cancer Diagnostics Company Cernostics Raises $1.4M Series B

Cernostics Inc., which is developing cancer diagnostics, has raised $1.4 million in Series B funding as it advances a test for esophageal cancer.   Original investors participating in the round include Geisinger Health System, Novitas Capital an... Read more

Cernostics Raises $1.4 Million in Series B Round

Cernostics, a diagnostics company focused on delivering next generation cancer diagnostics and prognostics through a unique approach to tissue analysis, announced today that it has raised $1.4 million in Series B funding. Original investors particip... Read more
Customer Service

Mon-Fri 9am-5pm (EST)